Pale Fire Capital SE’s Kura Oncology KURA Stock Holding History

Pale Fire Capital SE’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$621K	Sell	56,600 -800,874	-93%	-$7.56M	0.04%	39
2026 Q1	$6.97M	Buy	857,474 +405,229	+90%	+$3.48M	0.61%	19
2025 Q4	$4.7M	Sell	452,245 -155,545	-26%	-$1.63M	0.32%	23
2025 Q3	$5.38M	Buy	607,790 +587,690	+2,924%	+$4.19M	0.59%	16
2025 Q2	$116K	Buy	+20,100	New	+$123K	0.01%	52
2024 Q1	–	Sell	-31,050	Closed	-$446K	–	66
2023 Q4	$446K	Buy	31,050 +21,000	+209%	+$206K	0.07%	36
2023 Q3	$91.7K	Buy	+10,050	New	+$102K	0.01%	54

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Pale Fire Capital SE's KURA Position: Q2 2026 in Review

Pale Fire Capital SE reduced its Kura Oncology (KURA) stake by 93% in Q2 2026, selling an estimated $7.56M and leaving 56,600 shares worth $621K. The position accounts for 0.04% of the portfolio, ranked #39.

Pale Fire Capital SE first reported a position in KURA in Q3 2023 and has held it in 7 quarters since. The position peaked at $6.97M in Q1 2026. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

Pale Fire Capital SE held 56,600 shares of Kura Oncology worth $621K as of Q2 2026.
Pale Fire Capital SE sold 800,874 Kura Oncology shares in Q2 2026, an estimated $7.56M.
Kura Oncology made up 0.04% of Pale Fire Capital SE's portfolio in Q2 2026, its #39 holding.
Pale Fire Capital SE first reported a position in Kura Oncology in Q3 2023 and has held it in 7 quarters since.
Pale Fire Capital SE's Kura Oncology position peaked at $6.97M in Q1 2026.
220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Pale Fire Capital SE's 13F filing for Q2 2026, filed 13 Aug 2026.